Literature DB >> 29507012

SLE presenting as demyelinative autoimmune visual loss.

Ami Schattner1, Shilo Voichanski2, Livnat Uliel3.   

Abstract

A healthy 38-year-old woman developed sudden unilateral vision loss due to retrobulbar optic neuritis in the wake of varicella-zoster virus infection. She had no further central nervous system (CNS) lesions. Antinuclear antibodies (ANA) and anti-aquaporin 4 antibodies were found, consistent with neuromyelitis optica (NMO). Later, serial MRIs showed dynamic short-segment and long-segment myelitis lesions, ANA titre increased and additional autoantibodies were found including anti-dsDNA, anti-chromatin/nucleosome and antiphospholipid antibodies. In that setting, NMO can be regarded a rare presenting manifestation of systemic lupus erythematosus (SLE). The relevant literature is reviewed and the implications of NMO spectrum disorder demyelinating syndromes as the first manifestation of SLE (with or without antiphospholipid syndrome) (APS) or their later development (in a patient diagnosed with SLE) as part of the spectrum of neuropsychiatric SLE are analysed in view of recent research developments in the field. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  connective tissue disease; cranial nerves; immunology; neuroopthalmology; visual pathway

Mesh:

Substances:

Year:  2018        PMID: 29507012      PMCID: PMC5847934          DOI: 10.1136/bcr-2017-222158

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  47 in total

1.  Antinucleosome antibodies and primary antiphospholipid syndrome: an observational study.

Authors:  Alexandre Wagner Silva de Souza; Silene Peres Keusseyan; Neusa Pereira da Silva; Emilia Inoue Sato; Luis Eduardo Coelho Andrade
Journal:  Rev Bras Reumatol       Date:  2012 May-Jun

2.  Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus.

Authors:  L Barile-Fabris; R Ariza-Andraca; L Olguín-Ortega; L J Jara; A Fraga-Mouret; J M Miranda-Limón; J Fuentes de la Mata; P Clark; F Vargas; J Alocer-Varela
Journal:  Ann Rheum Dis       Date:  2005-04       Impact factor: 19.103

3.  The varicella-autoantibody syndrome.

Authors:  C Josephson; R Nuss; L Jacobson; M R Hacker; J Murphy; A Weinberg; M J Manco-Johnson
Journal:  Pediatr Res       Date:  2001-09       Impact factor: 3.756

Review 4.  Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines.

Authors:  Ami Schattner
Journal:  Vaccine       Date:  2005-04-07       Impact factor: 3.641

Review 5.  Paraneoplastic neuromyelitis optica spectrum disorders: three new cases and a review of the literature.

Authors:  Gang Cai; Dian He; Lan Chu; Qingqing Dai; Zhu Xu; Yifan Zhang
Journal:  Int J Neurosci       Date:  2015-08-18       Impact factor: 2.292

Review 6.  Demyelinating disease in SLE: is it multiple sclerosis or lupus?

Authors:  César Magro Checa; Danielle Cohen; Eduard L E M Bollen; Mark A van Buchem; Tom W J Huizinga; Gerda M Steup-Beekman
Journal:  Best Pract Res Clin Rheumatol       Date:  2013-06       Impact factor: 4.098

Review 7.  The spectrum of neuromyelitis optica.

Authors:  Dean M Wingerchuk; Vanda A Lennon; Claudia F Lucchinetti; Sean J Pittock; Brian G Weinshenker
Journal:  Lancet Neurol       Date:  2007-09       Impact factor: 44.182

8.  Clinicopathological features in anterior visual pathway in neuromyelitis optica.

Authors:  Mariko Hokari; Akiko Yokoseki; Musashi Arakawa; Etsuji Saji; Kaori Yanagawa; Fumihiro Yanagimura; Yasuko Toyoshima; Kouichirou Okamoto; Satoshi Ueki; Tetsuhisa Hatase; Riuko Ohashi; Takeo Fukuchi; Kohei Akazawa; Mitsunori Yamada; Akiyoshi Kakita; Hitoshi Takahashi; Masatoyo Nishizawa; Izumi Kawachi
Journal:  Ann Neurol       Date:  2016-02-22       Impact factor: 10.422

9.  Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study.

Authors:  J G Hanly; M B Urowitz; J Sanchez-Guerrero; S C Bae; C Gordon; D J Wallace; D Isenberg; G S Alarcón; A Clarke; S Bernatsky; J T Merrill; M Petri; M A Dooley; D Gladman; P R Fortin; K Steinsson; I Bruce; S Manzi; M Khamashta; A Zoma; C Aranow; E Ginzler; R Van Vollenhoven; J Font; G Sturfelt; O Nived; R Ramsey-Goldman; K Kalunian; J Douglas; K Thompson; V Farewell
Journal:  Arthritis Rheum       Date:  2007-01

Review 10.  The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease.

Authors:  Sonal Mehra; Marvin J Fritzler
Journal:  J Immunol Res       Date:  2014-04-03       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.